Higher dose data is absent
2022;387:205216), tirzepatide achieved mean weight loss of up to approximately 22.5% at the highest dose (15 mg) at 72 weeks in adults with obesity without diabetes results considered exceptional
For instance, in type 2 diabetes, GLP-1RAs improve glycemic control and reduce systemic inflammation
We need thousands of women to enroll in these trials so that we can figure out who are the best patients candidates for these drugs
Therefore, localized delivery methods, such as intravitreal implants, nanoparticle carriers, or gene therapy aimed at retinal GLP-1R expression, are essential for maximizing therapeutic effectiveness while minimizing systemic exposure
GLP1 medications repair signaling pathways that have been broken, often for years